You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Validation and Improvement of ISPRI-HCP: An Innovative Platform for Immunogenicity Risk Assessment of Process-related Protein Impurities

    SBC: EPIVAX, INC.            Topic: NIAID

    ABSTRACT The identification and removal of process-related protein impurities (PRPI) from biologic products is a critical step in drug development. Despite recent improvements in the purification and processing of biologics, the presence of immunogenic PRPI continue to raise concerns about drug safety and efficacy. We propose an innovative approach for assessing immunogenicity risk of PRPI using o ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia

    SBC: Haima Therapeutics LLC            Topic: NHLBI

    Project Summary/Abstract The normal platelet count in human blood is 150,000-400,000/μL, and these platelets are responsible for efficient hemostatic surveillance and bleeding mitigation in the body. Thrombocytopenia (TCP, low platelet count) is a condition caused by a decrease in platelet production, increase in platelet destruction or consumption, or increase in splenic sequestration. The age-a ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Ceragenin-coated pedicle screws to tackle surgical-site infections.

    SBC: N8 MEDICAL INC            Topic: NIAID

    PROJECT SUMMARY Surgical Site Infection (SSI) is one of the major complications of implant surgery, especially in spinal surgery, where SSI leads to unfavorable health and functional outcomes. Antimicrobial coatings have been explored as a way to prevent microbial colonization on the surface of pedicle screws. However, current strategies to generate antimicrobial coatings do not show broad-spectru ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

    SBC: IRXREMINDER LLC            Topic: 104

    Abstract - Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes Tardive dyskinesia (TDD) is a common debilitating side effect of antipsychotic use. Characterized most notably by involuntary facial movements such as grimacing, involuntary lip, mouth, and tongue movements, and eye blinking, TDD is difficult to treat and potentially irreversible. Psychiatrists and othe ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Suicide, depression, and anxiety screening using an automated virtual assistant

    SBC: CLARIGENT CORPORATION            Topic: 104

    Summary: Each year in the US, more than 47,000 people die by suicide and many of these tragedies could be prevented with early identification and treatment. At-risk individuals rarely receive screening until depression, anxiety, and suicide symptoms are severe. Universal screening tools deployed in schools and physicians’ offices could address this problem, but the lack of an objective tool alon ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. Development of CA-IL-12 for Triple Negative Breast Cancer

    SBC: CYTONUS THERAPEUTICS INC            Topic: 102

    Most cancer patients die as a result of metastatic disease and our inability to effectively deliver therapeutic drugs into the anatomical niches where cancer cells thrive. Thus, there is a major unmet need to develop therapeutic strategies that effectively target cancer cells in the local tumor microenvironment (TME) while minimizing peripheral toxicity. Cytonus Therapeutics and UCSD Moores Cancer ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants

    SBC: Thrive Neuromedical, LLC            Topic: NIDCD

    PROJECT DESCRIPTION Thrive Neuromedical LLC proposes to develop, test, and gain FDA clearance to market a therapeutic device to improve speech sound differentiation in preterm infants hospitalized in the neonatal intensive care unit (NICU). During this project we will complete development of the smallTalk NICU Active system and conduct a clinical trial to prove its efficacy in improving speech sou ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Development of Cortical Bone Mechanics Technology for Enhancing the Diagnosis of Osteoporosis

    SBC: OSTEODX INC            Topic: NIA

    ABSTRACT This Phase IIB SBIR grant application proposes to continue development and commercialization of OsteoDx’s Cortical Bone Mechanics Technology™ (CBMT™), a novel osteoporosis related diagnostic device that non- invasively measures the mechanical properties of cortical bone and provides direct information about bone strength and quality that is not accessible by other diagnostic modalit ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Developing a blood fatty acid-based algorithm as an early predictor of insulin resistance: Applying machine learning to harmonized data from prospective cohort studies

    SBC: OMEGAQUANT ANALYTICS, LLC.            Topic: 200

    Project Summary Metabolic diseases, such as Metabolic Syndrome (MetSyn) and type 2 diabetes (T2DM) affect ~37% and ~10% of Americans, respectively, with a substantial impact on the health, quality of life and financial security of these individuals. Without the means to identify high risk individuals conveniently and cheaply, many will find care too little and too late: more than 80% of individual ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Enabling Next Generation Machine Learning for Large Scale Image Analysis

    SBC: RNET TECHNOLOGIES INC            Topic: NIBIB

    Project Summary/Abstract Deep learning has transformed medical image analysis by delivering clinically meaningful results on challenging problems like prostate cancer detection and lung cancer screening. FDA approval of whole-slide digital pathology imaging (WSIs) for primary diagnosis is further increasing interest, adoption, and investment in artificial intelli- gence (AI) technology for patholo ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government